Immune Design Corp. 4
4 · Immune Design Corp. · Filed Jan 6, 2016
Insider Transaction Report
Form 4
PENHOET EDWARD
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2016-01-04+9,300→ 9,300 totalExercise: $19.39Exp: 2026-01-04→ Common Stock (9,300 underlying)
Footnotes (1)
- [F1]The shares underlying the option will become fully vested on January 4, 2017, subject to the Reporting Person's continuous service through such date.
Signature
/s/ Laura A. Berezin, Attorney-in-Fact|2016-01-06